Verquvo 2.5 mg
Verquvo 2.5 mg is a medicine authorised by Swissmedic under authorisation number 68001. The authorisation holder is Bayer (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 22 September 2021 and the authorisation is valid without a time limit. ATC code C01DX22 places the medicine in the group Cardiac therapy.
| Authorisation number | 68001 |
|---|---|
| Name | Verquvo 2.5 mg |
| Full name | Verquvo 2.5 mg, Filmtabletten |
| Authorisation holder | Bayer (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C01DX22 |
| First authorisation | 22 September 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Verquvo 2.5 mg, Filmtabletten | B | 22 September 2021 |
| 2 | Verquvo 5.0 mg, Filmtabletten | B | 22 September 2021 |
| 3 | Verquvo 10.0 mg, Filmtabletten | B | 22 September 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 14 | Tablette(n) | C01DX22 | 02.07.1. | B |
| 3 | 14 | Tablette(n) | C01DX22 | 02.07.1. | B |
| 4 | 28 | Tablette(n) | C01DX22 | 02.07.1. | B |
| 5 | 98 | Tablette(n) | C01DX22 | 02.07.1. | B |
| 7 | 14 | Tablette(n) | C01DX22 | 02.07.1. | B |
| 8 | 28 | Tablette(n) | C01DX22 | 02.07.1. | B |
| 9 | 98 | Tablette(n) | C01DX22 | 02.07.1. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Verquvo 2.5 mg authorised in Switzerland?
Yes. Verquvo 2.5 mg is authorised by Swissmedic under authorisation number 68001, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Verquvo 2.5 mg have?
Verquvo 2.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Verquvo 2.5 mg?
The authorisation holder is Bayer (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.